Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRS Features Data On ICD Survival, MRI-Safe Pacers, Device Replacements

This article was originally published in The Gray Sheet

Executive Summary

Encouraging results on defibrillator survival rates and imaging-safe pacemakers, along with more detailed outcomes data from device replacements, were among the biggest take-away items from the Heart Rhythm Society's annual scientific sessions held in Boston earlier this month
Advertisement

Related Content

Boston Scientific, Medtronic Heart Devices Go To Panel In March
Boston Scientific, Medtronic Heart Devices Go To Panel In March
AHA In Brief
AHA In Brief
MRI Coverage Proposals: A 'Go' For Blood Flow, 'No' For Pacemaker Patients
MRI Coverage Proposals: A 'Go' For Blood Flow, 'No' For Pacemaker Patients
“Real-World” ICD Benefit Displayed In Boston Sci Latitude Network Data
ABCD Study Results: Will Noninvasive T-Wave Test Boost ICD Referrals?
ABCD Study Results: Will Noninvasive T-Wave Test Boost ICD Referrals?

Topics

Advertisement
UsernamePublicRestriction

Register

MT027477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel